Menu Search
Equities

Guardant Health

GH*:MEX

Guardant Health

Actions
  • Price (MXN)672.00
  • Today's Change3.00 / 0.45%
  • Shares traded6.56k
  • 1 Year change+68.40%
  • Beta--
Data delayed at least 20 minutes, as of Nov 22 2024 11:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Guardant Health grew revenues 25.45% from 449.54m to 563.95m while net income improved from a loss of 654.59m to a smaller loss of 479.45m.
Gross margin60.31%
Net profit margin-74.02%
Operating margin-75.43%
Return on assets-30.72%
Return on equity-609.28%
Return on investment-35.19%
More ▼

Cash flow in USDView more

In 2023, Guardant Health increased its cash reserves by 698.66%, or 991.74m. Cash Flow from Investing totalled 840.25m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 324.98m for operations while cash generated from financing totalled 477.38m.
Cash flow per share-3.87
Price/Cash flow per share--
Book value per share-0.488
Tangible book value per share-0.5736
More ▼

Balance sheet in USDView more

Guardant Health has a Debt to Total Capital ratio of 105.56%, a lower figure than the previous year's 499.05%.
Current ratio6.22
Quick ratio5.85
Total debt/total equity--
Total debt/total capital1.06
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.